This Week in MedTech

This Week in MedTech is part of the MTI Newswire service for MTI subscribers and followers providing linked original content from leading industry sources as indicated. MedTech Intelligence nor the MTI Staff are involved with the writings of content shared below.

J&J agrees to purchase V-Wave

Johnson & Johnson said it will buy V-Wave in a deal worth up to $1.7 billion, with an upfront payment of $600 million. J&J intends to integrate the cardiovascular implant maker into its medtech segment. Read the story: MassDevice 8/19

Vyaire’s ventilator unit to be purchased by Zoll

Zoll will acquire Vyaire Medical’s ventilator business for an undisclosed sum. “If the acquisition is successfully completed, adding Vyaire’s ventilators to Zoll’s product portfolio will enhance our ability to serve a broader range of clinicians and patients,” Zoll CEO Jon Rennert said. Read the story > MassDevice (8/19)

New sizes of Guard’s wound therapy dressing cleared

The FDA has given 510(k) clearance to the larger sizes of Guard Medical’s NPseal negative pressure wound therapy dressing. The clearance allows the product to be used for dressing closed surgical incisions in cardiothoracic, cesarean and orthopedic procedures. Read the story > Medical Device Network (8/20)

Edwards continues M&A spree with Genesis’ TAVR tech

Edwards, which has made a series of acquisitions in recent months, is also investing $25 million in Singapore-based Genesis Medtech. Read the story > MedtechDive  8/19

FDA OKs first at-home syphilis test

NowDiagnostics’ over-the-counter test can return results in 15 minutes with a single drop of blood. Read the story > MedtechDive  8/19

Histosonics raises $102M for noninvasive treatment to destroy tumors

Using sound waves to break down tumor tissue can offer patients with liver cancer an alternative to surgery, radiation and chemotherapy. Read the story > MedtechDive  8/19

DuPont acquires Donatelle Plastics for $313M

The acquisition of the medical device contract manufacturer comes as DuPont prioritizes expansion in the healthcare sector. Read the story > MedtechDive  8/19

Caresyntax Rakes In $180M To Make Hospital ORs More Efficient

Caresyntax closed a $180 million Series C extension round, bringing its Series C fundraising total to $310 million. The company sells AI-based precision surgery technology that unifies operating room data on a single platform. Read the story > MedcityNews  8/18

Stryker to buy smart hospital technology firm Care.ai

The deal comes shortly after Stryker CEO Kevin Lobo told investors to expect a “very active deal pipeline” for the second half of 2024. Read the story > MedtechDive  8/12

Baxter agrees to sell kidney care unit to Carlyle for $3.8B

Selling the business, called Vantive, rather than spinning it off, should maximize shareholder value and give Baxter more flexibility to pursue other growth opportunities, the company said. Read the story > MedtechDive  8/13

Medtronic wins FDA approval for asleep deep brain stimulation

Medtronic said Monday it is the first company to receive FDA approval to offer DBS surgery while a patient is asleep or awake. Read the story > MedtechDive  8/13

Stereotaxis earns CE mark for new surgical robot

CEO David Fischel said the platform, called GenesisX, is designed to address challenges hospitals have faced when installing the company’s earlier robotic systems.  Read the story > MedtechDive  8/15